Jaffe E A, Hoyer L W, Nachman R L
J Clin Invest. 1973 Nov;52(11):2757-64. doi: 10.1172/JCI107471.
Antihemophilic factor (AHF, Factor VIII) antigen has been demonstrated in cultured human endothelial cells by immunofluorescence studies using monospecific rabbit antibody to human AHF. Control studies with cultured human smooth muscle cells and human fibroblasts were negative. By radioimmunoassay it was demonstrated that cultured human endothelial cells contain AHF antigen which is released into the culture medium. Cultured smooth muscle cells and fibroblasts did not have this property. Cultured endothelial cells incorporated radioactive amino acids into high molecular weight, AHF antigen-rich protein fractions prepared from the culture media, 7% of the radioactive amino acid counts incorporated into this material were precipitated by globulin prepared from rabbit anti-AHF whereas normal rabbit globulin precipitated only 1.5% of the counts. Although cultured endothelial cells actively synthesize AHF antigen, AHF procoagulant activity was not detected in the culture medium. Studies seeking a basis for the lack of procoagulant activity have not clarified this deficiency, but they have established that exogenous AHF procoagulant activity is not inactivated by the tissue culture system.
利用针对人抗血友病因子(AHF,凝血因子VIII)的单特异性兔抗体进行免疫荧光研究,已在培养的人内皮细胞中证实了AHF抗原。对培养的人平滑肌细胞和人成纤维细胞进行的对照研究结果为阴性。通过放射免疫测定法证明,培养的人内皮细胞含有AHF抗原,该抗原可释放到培养基中。培养的平滑肌细胞和成纤维细胞不具备此特性。培养的内皮细胞将放射性氨基酸掺入从培养基中制备的高分子量、富含AHF抗原的蛋白质组分中,掺入该物质的放射性氨基酸计数的7%可被兔抗AHF制备的球蛋白沉淀,而正常兔球蛋白仅沉淀计数的1.5%。尽管培养内皮细胞能积极合成AHF抗原,但在培养基中未检测到AHF促凝活性。旨在寻找缺乏促凝活性原因的研究尚未阐明这一缺陷,但已证实外源性AHF促凝活性不会被组织培养系统灭活。